Status:

UNKNOWN

Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Lead Sponsor:

Sormland County Council, Sweden

Conditions:

Vaccine Response Impaired

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Hepatitis A vaccine is the most frequently used traveler's vaccine, yet data on its ability to induce protective immunity in immunosuppressed travelers are scarce. The investigators assess the hepatit...

Detailed Description

Methods: Parameters registered at baseline were: age, sex, duration of disease, medications, activity of disease (Visual Analogue Scale), Health Assessment Questionnaire Disability Index, Disease Acti...

Eligibility Criteria

Inclusion

  • Diagnosis of rheumatoid arthritis
  • TNF-alfa blocker and / or methotrexate in use as a medication against RA
  • A desire to get protected against hepatitis A
  • Men and women age 18-65 years
  • Written informed consent
  • Women of childbearing potential must use effective contraception -

Exclusion

  • Treatment with rituximab within 9 months before study start
  • Known previous hepatitis A infection
  • Previous vaccination against hepatitis A
  • Allergy to eggs or formaldehyde
  • Pregnancy or lactation
  • Excessive use of alcohol
  • Mental retardation
  • Acute disease at the time of examination (fever \> 38 degrees)
  • Volunteer works as an employee of the researchers
  • Previous vaccination against hepatitis A
  • Egg-, hen-protein- or formaldehyde allergy
  • Pregnancy or lactation
  • Excessive use of alcohol
  • Another vaccine given within a month
  • Acute disease at the time of examination (fever \> 38 degrees)
  • Not suitable for other reason in the investigator's opinion (other serious disease, i.e. AIDS/HIV-positive, cancer with ongoing cytostatic treatment)

Key Trial Info

Start Date :

September 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2016

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT01446978

Start Date

September 1 2011

End Date

August 1 2016

Last Update

November 18 2015

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Dept infectious diseases

Eskilstuna, Sweden, 631 88

2

Dept infectious diseases

Örebro, Sweden, 70185

3

Department of infectious diseases

Stockholm, Sweden, 17176

4

Dept infectious diseases

Uppsala, Sweden, 75185